AI assistant
TRIFAST PLC — Director's Dealing 2024
Aug 21, 2024
4723_dirs_2024-08-21_5ce79638-36f8-42d7-9029-5fe71a73ff2d.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2637B
Trifast PLC
21 August 2024

Wednesday, 21 August 2024
Trifast plc
(the "Company")
Director/PDMR shareholding
The Company announces that, on Tuesday, 20 August , Mr. Christopher Morgan purchased 2,354 ordinary shares of 5 pence each in the Company ("Ordinary Shares") . Following this transaction, Mr. Morgan has a beneficial interest of 20,019 Ordinary Shares in the Company.
The notifications below is made in accordance with the requirements of the EU Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
Christopher Morgan
2.
Reason for the notification
a.
Position/status
Company Secretary
b.
Initial notification/Amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Trifast plc
b.
LEI
213800WFIVE6RWK3CR22
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been conducted
a.
Description of the financial instrument, type of instrument Identification code
Ordinary shares of 5 pence each
GB0008883927
b.
Nature of the transaction
Purchase of shares by Christopher Morgan
c.
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.8438 pence | 2,354 |
d.
Aggregated information
· Aggregated volume
· Price
2,354
£0.8438 pence
e.
Date of the transaction
20 August 2024
f.
Place of the transaction
London Stock Exchange, Main Market (XLON)
Enquiries:
Trifast plc
Lyndsey Case
Head of Governance
Tel: +44 (0) 1825 769696
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFZGZRRMMGDZG